AGF Investments LLC’s Juno Therapeutics, Inc. JUNO Stock Holding History

AGF Investments LLC’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-636	Closed	-$30K	–	871
2017 Q4	$30K	Buy	636 +196	+45%	+$9.78K	0.01%	349
2017 Q3	$19K	Buy	440 +128	+41%	+$4.36K	﹤0.01%	373
2017 Q2	$9K	Sell	312 -60	-16%	-$1.48K	﹤0.01%	659
2017 Q1	$9K	Sell	372 -92	-20%	-$1.97K	﹤0.01%	663
2016 Q4	$10K	Buy	+464	New	+$11.4K	﹤0.01%	672

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AGF Investments LLC's JUNO Position: Q1 2018 in Review

AGF Investments LLC sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 636 shares — an estimated $30K sold.

AGF Investments LLC first reported a position in JUNO in Q4 2016 and held it in 5 quarters. The position peaked at $30K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

AGF Investments LLC reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
AGF Investments LLC sold 636 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $30K.
AGF Investments LLC first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
AGF Investments LLC's Juno Therapeutics, Inc. position peaked at $30K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on AGF Investments LLC's 13F filing for Q1 2018, filed 4 May 2018.